1. 1049. Minimal Transient HIV-1 Viremia Following Vaccination Regimens Containing AD26. ZEBOV and MVA-BN-Filo in ART-Suppressed People Living with HIV. (4th December 2021) Authors: Custer, Benjamin L; Mwesigwa, Betty; Sawe, Fredrick; Oyieko, Janet; Ntinginya, Nyanda; Jani, Ilesh; Iroezindu, Michael; Hutter, Jack; Jagodzinski, Linda; Shukarev, Georgi; Eller, Leigh Anne; Ward, Lucy; Overman, Rachel; Rusnak, Janice M; Bounds, Callie; Badorrek, Christopher; Polyak, Christina; E... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly. Issue 44 (17th October 2016) Authors: Levin, Yotam; Kochba, Efrat; Shukarev, Georgi; Rusch, Sarah; Herrera-Taracena, Guillermo; van Damme, Pierre Journal: Vaccine Issue: Volume 34:Issue 44(2016) Page Start: 5262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks. Issue 2 (1st February 2017) Authors: Shukarev, Georgi; Callendret, Benoit; Luhn, Kerstin; Douoguih, Macaya Journal: Human vaccines & immunotherapeutics Issue: Volume 13:Issue 2(2017) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antibody-Dependent Natural Killer Cell Activation After Ebola Vaccination. (10th December 2019) Authors: Wagstaffe, Helen R; Clutterbuck, Elizabeth A; Bockstal, Viki; Stoop, Jeroen N; Luhn, Kerstin; Douoguih, Macaya; Shukarev, Georgi; Snape, Matthew D; Pollard, Andrew J; Riley, Eleanor M; Goodier, Martin R Journal: Journal of infectious diseases Issue: Volume 223:Number 7(2021) Page Start: 1171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials. Issue 32 (30th July 2022) Authors: Sadoff, Jerald; Le Gars, Mathieu; Brandenburg, Boerries; Cárdenas, Vicky; Shukarev, Georgi; Vaissiere, Nathalie; Heerwegh, Dirk; Truyers, Carla; de Groot, Anne Marit; Jongeneelen, Mandy; Kaszas, Krisztian; Tolboom, Jeroen; Scheper, Gert; Hendriks, Jenny; Ruiz-Guiñazú, Javier; Struyf, Frank; Van H... Journal: Vaccine Issue: Volume 40:Issue 32(2022) Page Start: 4403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022) Authors: Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda. Issue 1 (31st December 2020) Authors: Kitonsa, Jonathan; Ggayi, Abu-Baker; Anywaine, Zacchaeus; Kisaakye, Eva; Nsangi, Laura; Basajja, Vincent; Nyantaro, Mary; Watson-Jones, Deborah; Shukarev, Georgi; Ilsbroux, Ine; Robinson, Cynthia; Kaleebu, Pontiano Journal: Global health action Issue: Volume 13:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda. Issue 1 (31st December 2020) Authors: Kitonsa, Jonathan; Ggayi, Abu-Baker; Anywaine, Zacchaeus; Kisaakye, Eva; Nsangi, Laura; Basajja, Vincent; Nyantaro, Mary; Watson-Jones, Deborah; Shukarev, Georgi; Ilsbroux, Ine; Robinson, Cynthia; Kaleebu, Pontiano Journal: Global health action Issue: Volume 13:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda. Issue 1 (31st December 2020) Authors: Kitonsa, Jonathan; Ggayi, Abu-Baker; Anywaine, Zacchaeus; Kisaakye, Eva; Nsangi, Laura; Basajja, Vincent; Nyantaro, Mary; Watson-Jones, Deborah; Shukarev, Georgi; Ilsbroux, Ine; Robinson, Cynthia; Kaleebu, Pontiano Journal: Global health action Issue: Volume 13:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda. Issue 1 (31st December 2020) Authors: Kitonsa, Jonathan; Ggayi, Abu-Baker; Anywaine, Zacchaeus; Kisaakye, Eva; Nsangi, Laura; Basajja, Vincent; Nyantaro, Mary; Watson-Jones, Deborah; Shukarev, Georgi; Ilsbroux, Ine; Robinson, Cynthia; Kaleebu, Pontiano Journal: Global health action Issue: Volume 13:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗